NO20043984L - Ko-terapi for behandling av migrene omfattende antikonvulsantderivater og anti-migrenemidler - Google Patents

Ko-terapi for behandling av migrene omfattende antikonvulsantderivater og anti-migrenemidler

Info

Publication number
NO20043984L
NO20043984L NO20043984A NO20043984A NO20043984L NO 20043984 L NO20043984 L NO 20043984L NO 20043984 A NO20043984 A NO 20043984A NO 20043984 A NO20043984 A NO 20043984A NO 20043984 L NO20043984 L NO 20043984L
Authority
NO
Norway
Prior art keywords
migraine
therapy
treatment
agents
anticonvulsant derivatives
Prior art date
Application number
NO20043984A
Other languages
English (en)
Inventor
Lan R Livingstone
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20043984L publication Critical patent/NO20043984L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20043984A 2002-02-26 2004-09-23 Ko-terapi for behandling av migrene omfattende antikonvulsantderivater og anti-migrenemidler NO20043984L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35989402P 2002-02-26 2002-02-26
PCT/US2003/005463 WO2003072138A1 (en) 2002-02-26 2003-02-25 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents

Publications (1)

Publication Number Publication Date
NO20043984L true NO20043984L (no) 2004-09-23

Family

ID=27663315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043984A NO20043984L (no) 2002-02-26 2004-09-23 Ko-terapi for behandling av migrene omfattende antikonvulsantderivater og anti-migrenemidler

Country Status (18)

Country Link
US (2) US20030225002A1 (no)
EP (1) EP1478400A1 (no)
JP (1) JP2005518439A (no)
KR (1) KR101008326B1 (no)
CN (1) CN100352506C (no)
AU (1) AU2003213242A1 (no)
BR (1) BR0307951A (no)
CA (1) CA2419989A1 (no)
HR (1) HRP20040846A2 (no)
IL (2) IL163720A0 (no)
MX (1) MXPA04008259A (no)
NO (1) NO20043984L (no)
NZ (1) NZ534874A (no)
PL (1) PL372393A1 (no)
RU (1) RU2004126093A (no)
UA (1) UA81110C2 (no)
WO (1) WO2003072138A1 (no)
ZA (1) ZA200407729B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
AU2005215790A1 (en) 2004-02-17 2005-09-01 Sepracor Inc. Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
US20060233892A1 (en) * 2005-04-19 2006-10-19 Curt Hendrix Topiramate compositions for treatment of headache
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
FR2890564B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
EA023147B1 (ru) * 2006-04-13 2016-04-29 Тева Фармасьютикалс Интернешнл Гмбх Трансдермальный пластырь для лечения мигрени
EP2023894A4 (en) * 2006-04-25 2010-10-20 Applied Pharma Res FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
WO2008027557A2 (en) 2006-08-31 2008-03-06 Spherics, Inc. Topiramate compositions and methods of enhancing its bioavailability
EP2813144A1 (en) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Analgesic compositions comprising an antihistamine
MX2009001711A (es) 2006-11-17 2009-05-08 Supernus Pharmaceuticals Inc Formulaciones de liberacion sostenida de topiramato.
EP2363113B1 (en) * 2006-12-04 2017-08-02 Supernus Pharmaceuticals, Inc. Enhanced immediate release formulations of topiramate
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
CN102164603B (zh) * 2008-09-17 2015-11-25 麦克莱恩医院 用于治疗丛集性头痛症的方法和试剂盒
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP3423041A4 (en) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. PHARMACEUTICAL COMPOSITIONS
EP3523454A4 (en) * 2016-10-06 2020-06-03 Baylor College of Medicine PHOTOCHROMATIC MODULATION USING FLUORESCIN FOR THE TREATMENT OF PHOTOCOCULODYNIA AND BLEPHAROSPASM
CN113677348B (zh) * 2019-04-15 2025-02-18 费林药业公司 偏头痛的治疗

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
EP0942752B1 (en) * 1996-08-23 2005-04-20 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20020015713A1 (en) * 1996-10-24 2002-02-07 Murdock Robert W. Methods and transdermal compositions for pain relief
WO1998039018A1 (fr) * 1997-03-03 1998-09-11 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
US5855907A (en) * 1997-03-24 1999-01-05 Peyman; Gholam A. Method of treatment of migraine
US5935933A (en) * 1997-07-16 1999-08-10 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating neuropathic pain
US5760007A (en) * 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
CZ20012620A3 (cs) * 1999-01-19 2002-09-11 Ortho-Mcneil Pharmaceutical, Inc. Léčivo pro léčení histaminové cefalalgie
US6562865B1 (en) * 1999-08-20 2003-05-13 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and an anticonvulsant drug

Also Published As

Publication number Publication date
EP1478400A1 (en) 2004-11-24
BR0307951A (pt) 2004-12-21
PL372393A1 (en) 2005-07-25
US20070099849A1 (en) 2007-05-03
ZA200407729B (en) 2006-06-28
HRP20040846A2 (en) 2005-06-30
HK1080731A1 (en) 2006-05-04
MXPA04008259A (es) 2005-05-27
UA81110C2 (en) 2007-12-10
KR20040091074A (ko) 2004-10-27
CN1646168A (zh) 2005-07-27
NZ534874A (en) 2007-03-30
US20030225002A1 (en) 2003-12-04
RU2004126093A (ru) 2005-04-10
JP2005518439A (ja) 2005-06-23
WO2003072138A1 (en) 2003-09-04
KR101008326B1 (ko) 2011-01-13
IL163720A0 (en) 2005-12-18
CN100352506C (zh) 2007-12-05
CA2419989A1 (en) 2003-08-05
IL163720A (en) 2012-06-28
AU2003213242A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
NO20043984L (no) Ko-terapi for behandling av migrene omfattende antikonvulsantderivater og anti-migrenemidler
NO20044054L (no) Administrering av midler for behandling av betennelse
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
PL374831A1 (pl) Zmodyfikowane proleki 2' i 3'-nukleozydowe do leczenia zakażeń Flaviviridae
NO20054369D0 (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
NO20044195L (no) Biofosfoninsyrer for behandling og prevensjon av osteoprose
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
ATE417616T1 (de) Behandlung von mukositis
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
NO20041024D0 (no) Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene
NO20053874L (no) Formulering og metoder for behandling av thrombocytemi
GB2408558B (en) Treatment of pipes
DE60315490D1 (de) Therapeutische behandlung
DE60326190D1 (de) des Körpers
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
DE60222664D1 (de) Hautbehandlungsmittel
NO20052859D0 (no) Fremgangsmate for fremstilling av resperidon og intermediater derav
NO20040497L (no) Amidinderivater for behandling av amyloidose
AP2004003174A0 (en) Treatment of water
GB0210264D0 (en) The treatment of pain and migraine headache
SI1451177T1 (sl) Substituirani 2-pirolidin-2-il-1H-indolni derivati za zdravljenje migrene
ITBO20020148A0 (it) Apparato e metodo per la trasformazione del germe
GB0221712D0 (en) Methods of treatment
NO20033160D0 (no) Anordning for behandling av gravann